Abstract:P-glycoprotein (P-gp) is a key component of the intestinal epithelium playing a pivotal role in removal of toxins and efflux of endocannabinoids to prevent excessive inflammation and sustain homeostasis. Recent studies revealed butyrate and secondary bile acids, produced by the intestinal microbiome, potentiate the induction of functional P-gp expression. We now aim to determine the molecular mechanism by which this functional microbiome output regulates P-gp. RNA sequencing of intestinal epithelial cells responding to butyrate and secondary bile acids in combination discovered a unique transcriptional program involving multiple pathways that converge on P-gp induction. Using shRNA knockdown and CRISPR/Cas9 knockout cell lines, as well as mouse models, we confirmed the RNA sequencing findings and discovered a role for intestinal HNF4α in P-gp regulation. These findings shed light on a sophisticated signaling network directed by intestinal microbial metabolites that orchestrate P-gp expression and highlight unappreciated connections between multiple pathways linked to colonic health. IMPORTANCE Preventing aberrant inflammation is essential to maintaining homeostasis in the mammalian intestine. Although P-glycoprotein (P-gp) expression in the intestine is critical for protecting the intestinal epithelium from toxins and damage due to neutrophil infiltration, its regulation in the intestine is poorly understood. Findings presented in our current study have now uncovered a sophisticated and heretofore unappreciated intracellular signaling network or "reactome" directed by intestinal microbial metabolites that orchestrate regulation of P-gp. Not only do we confirm the role of histone deacetylases (HDAC) inhibition and nuclear receptor activation in P-gp induction by butyrate and bile acids, but we also discovered new signaling pathways and transcription factors that are uniquely activated in response to the combination of microbial metabolites. Such findings shed new light into a multi-tiered network that maintains P-gp expression in the intestine in the context of the fluctuating commensal microbiome, to sustain a homeostatic tone in the absence of infection or insult.

Microbial Metabolite Regulation of Epithelial Cell-Cell Interactions and Barrier Function

Epithelial regulation of microbiota-immune cell dynamics

Regulation of Intestinal Barrier Function by Microbial Metabolites

Gut Microbiota and Intestinal Trans-Epithelial Permeability

Border Control: The Role of the Microbiome in Regulating Epithelial Barrier Function

Microbiome-derived metabolite effects on intestinal barrier integrity and immune cell response to infection

Epithelial sensing of microbiota-derived signals

The role of mucosal barriers in human gut health

Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epithelium That Directs P-Glycoprotein Expression

Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity

Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier Function

Intestinal barrier: Molecular pathways and modifiers

Intestinal Permeability, Inflammation and the Role of Nutrients

Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions

The diet-microbiota axis: a key regulator of intestinal permeability in human health and disease

A single cell survey of the microbial impacts on the mouse small intestinal epithelium

Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier

Immune-epithelial interactions in host defense

Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation

Intestinal mucosal barrier function in health and disease